Cite
HARVARD Citation
Sax, P. et al. (n.d.). A Randomized Trial of Bictegravir or Dolutegravir with Emtricitabine and Tenofovir Alafenamide (F/TAF) Followed by Open Label Switch to Bictegravir/F/TAF Fixed Dose Combination. Open forum infectious diseases. pp. S426-S427. [Online].